Literature DB >> 28365811

Disuse osteopenia induced by botulinum toxin is similar in skeletally mature young and aged female C57BL/6J mice.

Jens Bay Vegger1, Annemarie Brüel2, Mikkel Bo Brent2, Jesper Skovhus Thomsen2.   

Abstract

Osteopenia and osteoporosis predominately occur in the fully grown skeleton. However, it is unknown whether disuse osteopenia in skeletally mature, but growing, mice resembles that of fully grown mice. Twenty-four 16-week-old (young) and eighteen 44-week-old (aged) female C57BL/6J mice were investigated. Twelve young and nine aged mice were injected with botulinum toxin in one hind limb; the remaining mice served as controls. The mice were euthanized after 3 weeks of disuse. The femora were scanned by micro-computed tomography (µCT) and bone strength was determined by mechanically testing the femoral mid-diaphysis and neck. At the distal femoral metaphysis, the loss of trabecular bone volume fraction (BV/TV) differed between the young and aged mice. However, at the distal femoral epiphysis, no age-dependent differences were observed. Thinning of the trabeculae was not affected by the age of the mice at either the distal femoral metaphysis or the epiphysis. Furthermore, the aged mice lost more bone strength at the femoral mid-diaphysis, but not at the femoral neck, compared to the young mice. In general, the bone loss induced by botulinum toxin did not differ substantially between young and aged mice. Therefore, the loss of bone in young mice resembles that of aged mice, even though they are not fully grown.

Entities:  

Keywords:  Aging; Immobilization; Mechanical testing; Mice; Micro-CT

Mesh:

Substances:

Year:  2017        PMID: 28365811     DOI: 10.1007/s00774-017-0830-y

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  8 in total

Review 1.  Botulinum Toxin A and Osteosarcopenia in Experimental Animals: A Scoping Review.

Authors:  Min Jia Tang; H Kerr Graham; Kelsey E Davidson
Journal:  Toxins (Basel)       Date:  2021-03-14       Impact factor: 4.546

2.  Botulinum toxin A-induced muscle paralysis stimulates Hdac4 and differential miRNA expression.

Authors:  Leah E Worton; Edith M Gardiner; Ronald Y Kwon; Leah M Downey; Brandon J Ausk; Steven D Bain; Ted S Gross
Journal:  PLoS One       Date:  2018-11-14       Impact factor: 3.240

3.  Zoledronic acid prevents disuse osteopenia and augments gene expression of osteoclastic differentiation markers in mice.

Authors:  Jens Bay Vegger; Annemarie Brüel; Jesper Skovhus Thomsen
Journal:  J Musculoskelet Neuronal Interact       Date:  2018-06-01       Impact factor: 2.041

4.  The Efficacy of PTH and Abaloparatide to Counteract Immobilization-Induced Osteopenia Is in General Similar.

Authors:  Mikkel Bo Brent; Jesper Skovhus Thomsen; Annemarie Brüel
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-09       Impact factor: 5.555

5.  Teriparatide and Abaloparatide Have a Similar Effect on Bone in Mice.

Authors:  Mikkel Bo Brent; Frederik Eriksen Stoltenborg; Annemarie Brüel; Jesper Skovhus Thomsen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-19       Impact factor: 5.555

Review 6.  A Systematic Review of Animal Models of Disuse-Induced Bone Loss.

Authors:  Annemarie Brüel; Jesper Skovhus Thomsen; Mikkel Bo Brent
Journal:  Calcif Tissue Int       Date:  2021-01-01       Impact factor: 4.333

7.  Pantoprazole, a proton pump inhibitor, does not prevent botulinum toxin induced disuse osteopenia in mice.

Authors:  J B Vegger; A Brüel; J S Thomsen
Journal:  J Musculoskelet Neuronal Interact       Date:  2017-09-01       Impact factor: 2.041

8.  The effect of oral dabigatran etexilate on bone density, strength, and microstructure in healthy mice.

Authors:  Mikkel Bo Brent; Jesper Skovhus Thomsen; Annemarie Brüel
Journal:  Bone Rep       Date:  2017-12-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.